OrbiMed’s GH Research GHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-736,315
| Closed | -$8.74M | – | 127 |
|
|
2023
Q2 | $8.74M | Sell |
736,315
-922,700
| -56% | -$10.9M | 0.16% | 91 |
|
|
2023
Q1 | $13.3M | Buy |
1,659,015
+36,955
| +2% | +$295K | 0.26% | 77 |
|
|
2022
Q4 | $15.8M | Hold |
1,622,060
| – | – | 0.3% | 68 |
|
|
2022
Q3 | $18.8K | Hold |
1,622,060
| – | – | 0.35% | 67 |
|
|
2022
Q2 | $16.2K | Buy |
1,622,060
+193,328
| +14% | +$1.93K | 0.29% | 72 |
|
|
2022
Q1 | $26.1M | Hold |
1,428,732
| – | – | 0.42% | 58 |
|
|
2021
Q4 | $33.3M | Buy |
1,428,732
+66
| +0% | +$1.54K | 0.43% | 64 |
|
|
2021
Q3 | $31.5M | Hold |
1,428,666
| – | – | 0.35% | 76 |
|
|
2021
Q2 | $31M | Buy |
+1,428,666
| New | +$31M | 0.31% | 76 |
|